Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...

A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) ...

Penn engineering researchers modified a fungus called Aspergillus flavus, which may have caused lung disease and illness in ...

Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood cancer multiple myeloma.

A new review was published in Volume 16 of Oncotarget on June 17, 2025, titled "Optimizing enfortumab vedotin plus ...

A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...

Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow—and how blocking them could help the body fight back.

Patients are put under anesthesia, and a rectal probe is placed which enables real-time imaging and treatment. After the machine takes an image of the prostate, the doctors outline the treatment area ...

We read with great interest the published results of the RADIOSA trial by Giulia Marvaso and colleagues.1 This well designed ...

The Biohacking Suite includes PEMF mats, lymphatic boots, red light panels, and binaural frequency chairs. Room lighting mimics the natural light spectrum, helping reset the body’s internal clock.